Chongqing Taiji Industry(Group) Co.,Ltd (SHA:600129)

Market Cap	12.04B
Revenue (ttm)	10.04B
Net Income (ttm)	-352.52M
Shares Out	551.42M
EPS (ttm)	-0.64
PE Ratio	n/a
Forward PE	23.48
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,164,649
Average Volume	9,596,073
Open	21.79
Previous Close	21.87
Day's Range	21.72 - 21.98
52-Week Range	18.70 - 29.49
Beta	0.44
RSI	46.21
Earnings Date	Oct 25, 2025

About SHA:600129

Chongqing Taiji Industry(Group) Co.,Ltd, together with its subsidiaries, develops, produces, and sells traditional Chinese and modern medicine products in China and internationally. It operates through Pharmaceutical Industry; Pharmaceutical Commercial; Chinese Herbal Medicine Resources; and Service Industry and Others segments. The company offers digestive system and metabolic, respiratory system, cardiovascular and cerebrovascular, anti-infective, nervous system, and anti-tumor and immunomodulatory drugs; and health products. It also engages ...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 11,971
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600129

Financial Performance

In 2024, SHA:600129's revenue was 12.39 billion, a decrease of -20.72% compared to the previous year's 15.62 billion. Earnings were 26.65 million, a decrease of -96.76%.